Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-033717
Filing Date
2019-05-31
Accepted
2019-05-31 18:24:35
Documents
1
Period of Report
2019-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 16767
  Complete submission text file 0001209191-19-033717.txt   18176
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNAVAX TECHNOLOGIES CORPORATION 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710-2753
Business Address
Spencer Ryan (Reporting) CIK: 0001777938 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 19871714